SMARCA2 / BRM Antibody

About the Target

SMARCA2 / BRM is a target of interest in many antibody-based workflows. SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily A member 2 (SMARCA2), also known as Brahma (BRM), is a key ATPase in the Snf2 family. BRM and its close relative, Brahma-related gene 1 (BRG1 or SMARCA4), are exclusive ATPases within the large ATP-dependent SWI/SNF chromatin-remodeling complexes, which play a critical role in gene expression regulation. Depending on the literature source, SMARCA2 / BRM may also be discussed as SMARCA2 / BRM and BRM.

Reported cellular context includes nucleus, which can matter when signal is compared across treatments or changing cell states. Following SMARCA2 / BRM across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

SMARCA2 / BRM is commonly interpreted in the context of epigenetics research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• signal enrichment within nucleus relative to the broader cellular background
• links between target behavior and transcriptional or chromatin-state changes
• co-patterning with orthogonal markers and control conditions that clarify pathway state
• time-matched comparisons so changes reflect biology rather than handling or sampling drift

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for SMARCA2 / BRM. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in SMARCA2 / BRM reflect biology rather than handling. When interpreting SMARCA2 / BRM, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep SMARCA2 / BRM trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.